Skip to Content
Merck

Atenolol-induced lupus erythematosus.

Journal of the American Academy of Dermatology (1997-08-01)
M McGuiness, R A Frye, J S Deng
ABSTRACT

Atenolol is a beta-blocker commonly used for treating hypertension. It can induce various kinds of adverse side effects, including psoriasiform skin eruptions, skin necrosis, vasculitis, and (rarely) drug-induced connective tissue disease. We encountered a patient receiving atenolol for his hypertension for 3 years who subsequently acquired connective tissue disease and antihistone antibodies. The initial serologic antinuclear antibody test was negative at a dilution of 1/20 but was positive after further serial dilutions, indicating the prozone phenomenon as the cause of the false-negative result. Six months after discontinuation of atenolol, the skin rash disappeared and antihistone antibody subsided. His skin rash reappeared on rechallenge with atenolol for 3 days, confirming that atenolol was responsible for his lupus erythematosus.

MATERIALS
Product Number
Brand
Product Description

Atenolol, European Pharmacopoeia (EP) Reference Standard
USP
Atenolol, United States Pharmacopeia (USP) Reference Standard
Supelco
Atenolol solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
Atenolol, ≥98% (TLC), powder